What is the proposed cellular mechanism linking GFAP mutation to astrocyte dysfunction in Alexander disease?
Rosenthal fiber accumulation and aberrant astrocyte Ca2+ signaling are both discussed as contributing mechanisms across gold documents — the underlying causal chain is still an active research question, not fully settled, and an answer should reflect that rather than overstate consensus (see benchmark_spec.md §Contradiction handling).
Generation outcome
Gold documents (3)
- [Alexander disease: diversity of cell population and interactions between neuron and glia].
- Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.
- Astrocyte-mediated infantile-onset leukoencephalopathy mouse model.
Retrieved documents (6)
- Mutations in GFAP Alter Early Lineage Commitment of Organoids.pubmed:40735838
- Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker.pubmed:25975510gold
- Clinical characteristics of Alexander disease.pubmed:32847470
- [Alexander disease: diversity of cell population and interactions between neuron and glia].pubmed:34193704gold
- Alexander disease.pubmed:29478608
- Astrocyte-Oligodendrocyte-Microglia Crosstalk in Astrocytopathies.pubmed:33328899
Generated claims (4)
GFAP is a type-3 intermediate filament protein mainly expressed in astrocytes in the central nervous system.
Mutations in GFAP can severely affect neural organoid development through altering lineage commitment in embryoid bodies.
Astrocyte dysfunction in the AxD brain is considered to be involved in its pathogenesis.
Aberrant Ca2+ signals in astrocytes were associated with the upregulation of reactive phenotype.